Pharmaceutical

Bicycle Therapeutics plans $200m public offering

The offering follows recent lucrative deals with Novartis and Bayer for the use of Bicycle Therapeutics’ peptide technology.

Jul 15, 2023 - 20:00
Bicycle Therapeutics plans $200m public offering
The offering follows recent lucrative deals with Novartis and Bayer for the use of Bicycle Therapeutics’ peptide technology.
Read the original article

Tags:

Previous Article

Listen: Wegovy in the brain, pivotal Alzheimer’s data, & pulling Threads

Next Article

Causaly secures $60 Million in series B funding

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

STAT+: Pharmalittle: Nearly half of U.S. adults would spend $100 a month for weight loss drugs; Pfizer scraps an obesity pill

STAT+: Pharmalittle: Nearly half of U.S. adults would s...

Jun 26, 2023

Opinion: Why the debate over proposed nursing home staff minimums is particularly unproductive

Opinion: Why the debate over proposed nursing home staf...

Feb 5, 2024

UAE MoHAP and Novo Nordisk partner for obesity management

UAE MoHAP and Novo Nordisk partner for obesity management

Sep 4, 2024